Abstract:Study question To investigate the potential mediation role of lipid metabolism on the effect of glucose metabolism on IVF/ICSI outcomes in PCOS women. Summary answer Lipid metabolism indicators were possible mediators of the effect of glucose metabolism indicators on IVF/ICSI early reproductive outcomes in PCOS women. What is known already Women with PCOS have high incidences of dyslipidemia, obesity, impaired glucose tolerance (IGT), diabetes, and insulin resistance (IR) and are fragile to female infertility. The causality between dyslipidemia, glucose homeostasis dysregulation, and IR has been widely discussed. Dyslipidemia may be an intermediate biological mechanism for the associations between abnormal glucose metabolism and potential disorders of oocytogenesis and embryogenesis in PCOS women. Study design, size, duration We retrospectively analyzed 917 PCOS women aged between 20 – 45 years old who underwent their first fresh IVF/ICSI cycle with autologous oocytes during 2018 – 2020 at a reproductive center. Participants/materials, setting, methods Data on baseline reproductive and cycle characteristics were collected from the internal database derived from the electronic medical records. The pregnancy outcomes were collected by well-trained follow-up staff from telephone interviews. Associations between glucose and lipid metabolism indicators and IVF/ICSI outcomes were explored using multivariable generalized linear regressions. Mediation analyses were conducted to examine the role of lipid metabolism on the association between glucose metabolism and IVF/ICSI outcomes. Main results and the role of chance Significant dose-dependent relationships were found between glucose metabolism indicators and IVF/ICSI early reproductive outcomes, as well as between glucose metabolism indicators and lipid metabolism indicators (all P < 0.05). Also, we found significant dose-dependent relationships between lipid metabolism indicators and IVF/ICSI early reproductive outcomes (all P < 0.05). The mediation analysis indicated that elevated FPG, 2hPG, FPI, 2hPI, HbA1c, and HOMA2-IR were significantly associated with decreased retrieved oocyte count, MII oocyte count, normal fertilization count, normal cleavage count, high-quality embryo count, or blastocyst formation count after controlling for lipid metabolism indicators. Serum TG mediated 6.0 – 31.0% of the associations; serum TC mediated 6.1 – 10.8% of the associations; serum HDL-C mediated 9.4 – 43.6% of the associations; serum LDL-C mediated 4.2 – 18.2% of the associations; and BMI mediated 26.7 – 97.7% of the associations. Limitations, reasons for caution Given the retrospective nature, bias in data collection cannot be excluded. Besides, we did not consider any adjunctive therapy, including diet, exercise, or medication (i.e., metformin) before or during IVF treatment. The possible random errors in single measurements may also lead to certain imprecise estimates of association. Wider implications of the findings Our study emphasizes a mediation role of lipid metabolism in the impact of glucose metabolism on oocytogenesis and embryogenesis in PCOS women, suggesting that the monitoring and management of preconception lipid metabolism, glucose homeostasis, and IR are essential for improving the IVF/ICSI outcomes of PCOS women. Trial registration number Not Applicable

Lipid Metabolic Disorders and Ovarian Hyperstimulation Syndrome: A Retrospective Analysis.

Risk of Higher Blood Pressure in 3 to 6 Years Old Singleton Born from OHSS Patients Undergone with Fresh IVF/ICSI.

The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium.

Research on the Protocol of Limited Ovarian Stimulation to Prevent Ovarian Hyperstimulation Syndrome

Lipid Analysis of Follicular Fluids by UHPLC-ESI-HRMS Discovers Potential Biomarkers for Ovarian Hyperstimulation Syndrome

Obstetric Outcome Analyses of 132 Cycles in Vitro Fertilized Pregnancies Complicated by Moderate and Severe Ovarian Hyperstimulation Syndrome

Effect of hyperlipidemia on the outcome of in vitro fertilization in non-obese patients with polycystic ovary syndrome

Lipid Metabolism Was Associated With Oocyte in vitro Maturation in Women With Polycystic Ovarian Syndrome Undergoing Unstimulated Natural Cycle

Intrafollicular fluid metabolic abnormalities in relation to ovarian hyperstimulation syndrome: Follicular fluid metabolomics via gas chromatography-mass spectrometry

Clinical Analyses for 93 Cycles of Moderate and Severe Ovarian Hyperstimulation Syndrome

Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?

Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI

Cardiovascular dysfunction in children born to women with ovarian hyperstimulation syndrome: a retrospective cohort study and proteomics analysis

Overweight and obesity negatively affect the outcomes of ovarian stimulation and invitro fertilisation: A cohort study of 2628 Chinese women

Effects of Dyslipidemia on In-Vitro Fertilization/intracytoplasmic Sperm Injection (IVF/ICSI) Pregnancy Outcome in Patients with Polycystic Ovary Syndrome(pcos)

Sequential Combination of Drugs in the Prevention and Treatmentof Moderate and Severe OHSS

[Clinical Characteristics of Severe Late-Onset Ovarian Hyperstimulation Syndrome and Its Impact on the Live Birth Outcome of IVF-ET].

Metabolic landscape and pathogenic insights: a comprehensive analysis of high ovarian response in infertile women undergoing in vitro fertilization

The Incidence of Moderate and Severe Ovarian Hyperstimulation Syndrome in Hospitalized Patients in China.

Cardiovascular dysfunction in offspring of ovarian-hyperstimulated women and effects of estradiol and progesterone: a retrospective cohort study and proteomics analysis.

P-610 Lipid Metabolism Mediated the Effect of Glucose Homeostasis and Insulin Resistance on IVF/ICSI Outcomes in PCOS Women